751 related articles for article (PubMed ID: 30705437)
1. Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction-DAP-SPEED Study.
Tuken M; Culha MG; Serefoglu EC
Int J Impot Res; 2019 Mar; 31(2):92-96. PubMed ID: 30705437
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial.
Abu El-Hamd M; Abdelhamed A
Andrologia; 2018 Feb; 50(1):. PubMed ID: 28497478
[TBL] [Abstract][Full Text] [Related]
4. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials.
Porst H; McMahon CG; Althof SE; Sharlip I; Bull S; Aquilina JW; Tesfaye F; Rivas DA
J Sex Med; 2010 Jun; 7(6):2231-2242. PubMed ID: 20412423
[TBL] [Abstract][Full Text] [Related]
5. The Combination of Dapoxetine and Behavioral Treatment Provides Better Results than Dapoxetine Alone in the Management of Patients with Lifelong Premature Ejaculation.
Cormio L; Massenio P; La Rocca R; Verze P; Mirone V; Carrieri G
J Sex Med; 2015 Jul; 12(7):1609-15. PubMed ID: 26077706
[TBL] [Abstract][Full Text] [Related]
6. Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study.
Lee WK; Lee SH; Cho ST; Lee YS; Oh CY; Yoo C; Cho JS; Lee SK; Yang DY
J Sex Med; 2013 Nov; 10(11):2832-41. PubMed ID: 23937271
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of Yimusake Tablets plus dapoxetine hydrochloride in the treatment of premature ejaculation].
Yan XQ; Li YF; Yang DK; Jiao X
Zhonghua Nan Ke Xue; 2016 Sep; 22(9):817-822. PubMed ID: 29071880
[TBL] [Abstract][Full Text] [Related]
8. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
Shabsigh R; Patrick DL; Rowland DL; Bull SA; Tesfaye F; Rothman M
BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300
[TBL] [Abstract][Full Text] [Related]
9. Novel Treatment for Premature Ejaculation in the Light of Currently Used Therapies: A Review.
Porst H; Burri A
Sex Med Rev; 2019 Jan; 7(1):129-140. PubMed ID: 30057136
[TBL] [Abstract][Full Text] [Related]
10. Assessing satisfaction in men with premature ejaculation after dapoxetine treatment in real-world practice.
Jiann BP; Huang YJ
Int J Clin Pract; 2015 Nov; 69(11):1326-33. PubMed ID: 26194604
[TBL] [Abstract][Full Text] [Related]
11. The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX).
McMahon C; Althof S; Rosen R; Giuliano F; Miner M; Osterloh IH; Muirhead GJ; Harty B;
J Sex Med; 2019 Aug; 16(8):1178-1187. PubMed ID: 31351659
[TBL] [Abstract][Full Text] [Related]
12. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
McMahon C; Kim SW; Park NC; Chang CP; Rivas D; Tesfaye F; Rothman M; Aquilina J;
J Sex Med; 2010 Jan; 7(1 Pt 1):256-68. PubMed ID: 19878447
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials.
McMahon CG; Althof SE; Kaufman JM; Buvat J; Levine SB; Aquilina JW; Tesfaye F; Rothman M; Rivas DA; Porst H
J Sex Med; 2011 Feb; 8(2):524-39. PubMed ID: 21059176
[TBL] [Abstract][Full Text] [Related]
14. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial.
Kaufman JM; Rosen RC; Mudumbi RV; Tesfaye F; Hashmonay R; Rivas D
BJU Int; 2009 Mar; 103(5):651-8. PubMed ID: 19021601
[TBL] [Abstract][Full Text] [Related]
15. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
Dinsmore WW; Wyllie MG
BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of dapoxetine in the treatment of premature ejaculation].
Chen XY; Qu YW; Wang SG
Zhonghua Nan Ke Xue; 2016 May; 22(5):411-4. PubMed ID: 27416664
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of dapoxetine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.
Safarinejad MR
Neuropsychopharmacology; 2008 May; 33(6):1259-65. PubMed ID: 17625501
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of epelsiban in the treatment of men with premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose study.
Shinghal R; Barnes A; Mahar KM; Stier B; Giancaterino L; Condreay LD; Black L; McCallum SW
J Sex Med; 2013 Oct; 10(10):2506-17. PubMed ID: 23937679
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of the efficacy of daily paroxetine/tadalafil combination in patients with premature ejaculation and erectile dysfunction.
Onal B; Can O; Ermec B; Culha MG
Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4248-4253. PubMed ID: 37203851
[TBL] [Abstract][Full Text] [Related]
20. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries.
Buvat J; Tesfaye F; Rothman M; Rivas DA; Giuliano F
Eur Urol; 2009 Apr; 55(4):957-67. PubMed ID: 19195772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
